Company news

AXIM Biotechnologies, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

AXIM® Biotechnologies Receives Seventh Private Label Gum Purchase Order Pushing Orders to Nearly $900,000 for Last Five Months

July 11, 2019

AXIM® Biotechnologies Signs Licensing Agreement With Leading Gum Distributor to Expand Nutraceutical Division

July 9, 2019

AXIM® Biotechnologies Signs Supply Agreement to Register Cannabinoid Oral Care Products in Clinical Trials for Gingivitis and Gum Disease

June 25, 2019

FOX Business Features Opinion Article Authored by AXIM Biotechnologies, Inc. CEO on Why Legal CBD is Good for Consumers and the Economy

June 5, 2019

AXIM® Biotechnologies, Inc. Signs Cannabinoid Product Supply Agreement with Healthcare Company for Clinical Trials on Treatment of Periodontitis

June 3, 2019

Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

May 17, 2019

AXIM® Biotechnologies Announces Additional Purchase Order for Nutraceutical Product With Leading Direct Selling Company

May 15, 2019

Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

May 14, 2019

AXIM® Biotechnologies to Present at Cannastocks 2019 Q1 Conference

May 14, 2019

AXIM® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

May 9, 2019

AXIM® Biotechnologies, Inc. Nutraceutical Division Receives Purchase Order for 50,000 Boxes of the Company’s Proprietary CBD-Based Chewing Gum

April 23, 2019

AXIM® Biotechnologies, Inc. Announces Attendance and Presentation by Chief Technology Officer Lekhram Changoer at Kannaway® “Believe” National Convention

April 12, 2019

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Enters Services Agreement with CRO to Begin Clinical Studies on Dronabinol and CBD Chewing Gums

April 10, 2019

AXIM® Biotech Enters Services Agreement With CRO to Begin Clinical Studies On Dronabinol and CBD Chewing Gums

April 9, 2019

AXIM® Biotechnologies, Inc. Appoints Mauricio Javier Gatto-Bellora to Company’s Board of Directors

April 4, 2019

Medical Marijuana, Inc. Portfolio Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Topical Cream Containing Cannabinoids

March 27, 2019

Axim® Biotechnologies Receives New U.S. Patent Issuance for Topical Cream Containing Cannabinoids

March 19, 2019

AXIM® Biotechnologies Announces Successful Microencapsulation of Cannabinoids Into Proprietary Chewing Gum Delivery Mechanism for Clinical Trials

February 26, 2019

Medical Marijuana, Inc. Subsidiary Kannaway® Places Significant Initial Purchase Order for Major Investment Company AXIM® Biotechnologies CBD Chewing Gum

February 14, 2019

AXIM® Biotechnologies Announces Significant Initial Purchase Order for Nutraceutical Product With Leading Direct Selling Company

February 12, 2019

New U.S. Patent Issuance Granted to AXIM® Biotechnologies for Oral Care Composition Containing Cannabinoids

January 29, 2019

AXIM® Biotechnologies Launches New Website and Management Presentation To Outline Strategic Business Initiatives

January 15, 2019

AXIM® Biotechnologies Appoints New Chief Executive Officer

January 8, 2019

New U.S. Patent Allowance Granted to AXIM® Biotechnologies for Suppository Formulations Comprised of Cannabinoids

October 23, 2018

Axim® Biotechnologies Earns GMP License From Dutch Ministry of Health to Produce Cannabinoid-Based Pharmaceutical Products

October 16, 2018

AXIM® Biotechnologies Signs LOI for Distribution of Products Throughout Australia and New Zealand

September 13, 2018

AXIM® Biotechnologies Enters Canadian Market Through New Exclusive Distribution and License Agreement With Revive Therapeutics

August 27, 2018

AXIM® Biotechnologies to Present at BIT’s 16th Annual Congress of International Drug Discovery Science and Technology

August 15, 2018

Axim® Biotechnologies Announces Positive Results From Stability And Dissolution Tests On Medchew Rx Showing Greater Than 90% Availability

August 7, 2018

AXIM® Biotechnologies to Present at 28th Annual International Cannabinoid Research Society Symposium in The Netherlands

June 28, 2018

New U.S. Patent Allowance Granted to AXIM® Biotechnologies for Extraction and Purification of Delta-9-THC For Use in MedChew RX Clinical Program

June 19, 2018

AXIM Biotechnologies Advances Dronabinol Therapeutic Equivalence Program Through Purchase Agreement With Noramco

May 15, 2018

AXIM Biotech Secures Additional Funding to Advance Cannabidnoid-Based Clinical Development Program for Multiple Indications

April 23, 2018

AXIM Biotech Files Patent Application on Product Formulation Comprised of Cannabinoids With Anti-Bacterial and Anti-Fungal Activities

April 18, 2018

AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South Korea

April 3, 2018

AXIM Biotech to Attend BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference in New York

March 21, 2018

AXIM Biotechnologies Reports Year End 2017 Results

March 19, 2018

Medical Marijuana, Inc. Major Investment AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules

February 28, 2018

AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules

February 27, 2018

CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction

February 21, 2018

AXIM Biotech Enters Into Distribution Agreement for Proprietary Cannabinoid-Based Nutraceutical Chewing Gum Product CanChew+ Throughout Thailand

February 6, 2018

AXIM Biotech Announces Successful Completion of Exploratory Meeting with the Dutch Medicines Evaluation Board on MedChew Rx Program for Treatment of Pain and Spasticity in MS Patients

January 23, 2018

AXIM Biotech Attends Biotech Showcase Conference in San Francisco

January 4, 2018

AXIM Biotech Announces Successful Completion of Pre-IND Meeting with FDA on Comparable Product to Marinol; Green Light from FDA for IND Submission

December 12, 2017

Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com

December 11, 2017

Leading CBD Provider Reports 255% Revenue Growth -- CFN Media

November 27, 2017

Axim Biotechnologies Reports Third Quarter 2017 Results

November 22, 2017

Medical Marijuana, Inc. Reports Third Quarter 2017 Financial Results and Operational Highlights: Shows Record 255% Gross Profit Increase

November 21, 2017

Axim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid Delivery Method for Treatment of Irritable Bowel Syndrome (IBS)

November 21, 2017

AXIM Targets Cannabinoid-based Ophthalmic Solutions -- SECFilings.com

October 25, 2017

← Newer news releases · Older news releases →

Decks